• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名轻症新型冠状病毒肺炎患者的严重低钠血症:抗利尿激素分泌异常综合征和肾上腺功能不全的诊断挑战

Severe hyponatremia in a mild COVID-19 patient: diagnostic challenges of SIADH and adrenal insufficiency.

作者信息

Takano Shinnosuke, Beppu Hiroko, Fukuda Tatsuya, Ogawa Toshie, Kawanishi Tomoko, Kimura Hitomi, Endo Mariko, Abe Yasutomo

机构信息

Department of Nephrology, Tokyo Metropolitan Okubo Hospital, Tokyo, Japan.

Department of Endocrinology and Metabolism, Tokyo Metropolitan Okubo Hospital, Tokyo, Japan.

出版信息

CEN Case Rep. 2025 May 2. doi: 10.1007/s13730-025-00995-2.

DOI:10.1007/s13730-025-00995-2
PMID:40314920
Abstract

This case report presents a 57-year-old Japanese woman with mild COVID-19 who developed severe symptomatic hyponatremia and altered consciousness, notably without pneumonia or central nervous system infection. Initial findings, including low plasma osmolality, high urine osmolality, and elevated IL-6 levels, suggested that the syndrome of inappropriate antidiuretic hormone secretion (SIADH) was the primary cause of her hyponatremia. While initial saline infusion offered temporary symptom relief, sodium levels remained unstable, leading to intermittent steroid therapy. Her improvement with steroids, alongside additional hormonal testing, raised the possibility of partial adrenal insufficiency as a complicating factor. Although secondary adrenal insufficiency in COVID-19 cases has been previously reported, its exact contribution to hyponatremia remains unclear. This case underscores the diagnostic complexities in managing hyponatremia associated with COVID-19, as SIADH is often the leading cause but may not fully explain persistent cases unresponsive to standard treatments. The report also emphasizes the importance of considering adrenal insufficiency in similar cases, particularly given COVID-19's potential impact on the hypothalamic-pituitary-adrenal axis. This case highlights the need for further research into COVID-19's effects on hormonal regulation, as such disruptions may play a key role in COVID-19-related electrolyte imbalances.

摘要

本病例报告介绍了一名57岁的日本女性,患有轻度新冠肺炎,出现了严重的症状性低钠血症和意识改变,尤其没有肺炎或中枢神经系统感染。包括低血浆渗透压、高尿渗透压和白细胞介素-6水平升高在内的初始检查结果表明,抗利尿激素分泌不当综合征(SIADH)是其低钠血症的主要原因。虽然最初输注生理盐水提供了暂时的症状缓解,但钠水平仍不稳定,导致间歇性使用类固醇治疗。她使用类固醇后病情改善,以及进一步的激素检测,增加了存在部分肾上腺功能不全作为一个复杂因素的可能性。虽然此前已有新冠肺炎病例继发肾上腺功能不全的报道,但其对低钠血症的确切影响仍不清楚。本病例强调了管理与新冠肺炎相关的低钠血症时的诊断复杂性,因为SIADH通常是主要原因,但可能无法完全解释对标准治疗无反应的持续性病例。该报告还强调了在类似病例中考虑肾上腺功能不全的重要性,特别是考虑到新冠肺炎对下丘脑-垂体-肾上腺轴的潜在影响。本病例突出了对新冠肺炎对激素调节影响进行进一步研究的必要性,因为这种干扰可能在与新冠肺炎相关的电解质失衡中起关键作用。

相似文献

1
Severe hyponatremia in a mild COVID-19 patient: diagnostic challenges of SIADH and adrenal insufficiency.一名轻症新型冠状病毒肺炎患者的严重低钠血症:抗利尿激素分泌异常综合征和肾上腺功能不全的诊断挑战
CEN Case Rep. 2025 May 2. doi: 10.1007/s13730-025-00995-2.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: a case report and literature review.伴有肾上腺危象的2型全三联自身免疫性多内分泌综合征延迟诊断:一例报告及文献综述
Front Immunol. 2025 May 9;16:1563629. doi: 10.3389/fimmu.2025.1563629. eCollection 2025.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.儿童急性淋巴细胞白血病糖皮质激素治疗后下丘脑-垂体-肾上腺(HPA)轴抑制
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD008727. doi: 10.1002/14651858.CD008727.pub4.
6
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
7
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
8
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
9
Colchicine for the treatment of COVID-19.秋水仙碱治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD015045. doi: 10.1002/14651858.CD015045.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

本文引用的文献

1
New onset of isolated adrenocorticotropin deficiency associated with encephalopathy following coronavirus disease 2019 in a healthy elderly man.一名健康老年男性在感染 2019 冠状病毒病后出现孤立性促肾上腺皮质激素缺乏伴脑病。
Endocr J. 2024 Mar 28;71(3):305-312. doi: 10.1507/endocrj.EJ23-0550. Epub 2024 Jan 20.
2
Hypothalamic-Pituitary-Adrenal Axis Activity in SARS-CoV-2 Infected Noncritically Ill Hospitalized Patients.新型冠状病毒感染非危重症住院患者的下丘脑-垂体-肾上腺轴活性。
J ASEAN Fed Endocr Soc. 2023;38(2):65-70. doi: 10.15605/jafes.038.02.04. Epub 2023 Jul 3.
3
Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH) With Severe Hyponatremia As the Initial and Sole Presentation of COVID-19 Infection: A Case Report and Pathophysiologic Insights.
抗利尿激素不适当分泌综合征(SIADH)伴严重低钠血症作为新冠病毒感染的首发及唯一表现:一例报告及病理生理学见解
Cureus. 2023 Jan 24;15(1):e34161. doi: 10.7759/cureus.34161. eCollection 2023 Jan.
4
Prevalence and outcomes of hyponatremia among COVID-19 patients: A systematic review and meta-analysis.COVID-19患者低钠血症的患病率及预后:一项系统评价和荟萃分析。
Int J Health Sci (Qassim). 2022 Sep-Oct;16(5):69-84.
5
Kidney Transplant Recipient with Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Secondary to COVID-19 Pneumonia: A Case Report.一名因新冠病毒肺炎继发抗利尿激素分泌异常综合征(SIADH)的肾移植受者:病例报告
Transplant Proc. 2022 Jul-Aug;54(6):1539-1542. doi: 10.1016/j.transproceed.2022.04.001. Epub 2022 Apr 11.
6
Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD).患者评估:低钠血症和抗利尿激素分泌不当综合征(SIAD)。
J Clin Endocrinol Metab. 2022 Jul 14;107(8):2362-2376. doi: 10.1210/clinem/dgac245.
7
Hyponatremia in COVID-19 infection: One should think beyond SIADH.新型冠状病毒肺炎感染中的低钠血症:不应仅考虑抗利尿激素分泌异常综合征。
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S522-S524. doi: 10.1016/j.mjafi.2021.02.011. Epub 2021 Jul 26.
8
Hyponatremia and Encephalopathy in a 55-Year-old Woman with Syndrome of Inappropriate Antidiuretic Hormone Secretion as an Isolated Presentation of SARS-CoV-2 Infection.55 岁女性以抗利尿激素分泌不当综合征为唯一表现的 SARS-CoV-2 感染导致的低钠血症和脑病。
Am J Case Rep. 2021 Mar 24;22:e930135. doi: 10.12659/AJCR.930135.
9
Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19.新型冠状病毒肺炎住院患者低钠血症和高钠血症的患病率及转归
Nephrol Dial Transplant. 2021 May 27;36(6):1135-1138. doi: 10.1093/ndt/gfab067.
10
SARS-CoV-2-induced SIADH: a novel cause of hyponatremia.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的抗利尿激素分泌异常综合征:低钠血症的新病因
Z Gerontol Geriatr. 2021 May;54(3):301-304. doi: 10.1007/s00391-021-01863-1. Epub 2021 Mar 1.